Tagra Biotechnologies, since its inception in 1998, focuses on developing and manufacturing microencapsulated ingredients such as actives, pigments, essential oils, UV filters, and highly water-soluble ingredients.
Tagra is the first to patent a unique innovative Release on Demand™ (RND™) Microencapsulation Technology. Tagra’s platform addresses industry challenges of stability, efficiency, and compatibility with other cosmetic and pharmaceutical formulation ingredients. The technology enables the masking, protecting, and releasing of more than 40 actives and pigments widely used in cosmetics and OTC preparations. Tagra’s microcapsules are friction released through consumer applications.
Tagra also owns and operates its own plant and state-of-the-art laboratory meeting all required regulations.
CelluCap™ VBE is a non-nano product that is based on Tagra’s Release on Demand™ (RND™) technology, which enables optimal isolation of the Vanillyl Butyl Ether. CelluCap™ VBE has been proven to maintain actives levels in formulations during stability trial...Vea Mas
CelluCap™ VBE is a non-nano product that is based on Tagra’s Release on Demand™ (RND™) technology, which enables optimal isolation of the Vanillyl Butyl Ether. CelluCap™ VBE has been proven to maintain actives levels in formulations during stability trials and helps prevent formula discoloration. CelluCap™ VBE is easily incorporated into almost all formulation types, and brings a gentle warming sensation to massage creams, lip products, facial masks, scalp treatments, and many other products. Vea Menos
WS SA50™ consists of encapsulated Salicylic Acid, 50% payload. WS SA50™ increases Salicylic Acid water solubility from 0.2% to 5% and maintains an acidic pH.
Upgrade to a premium Prospector account to filter by ingredient properties and view compliance highlights. These features can help you make smarter formulation decisions with instant access to:
Search by physical and chemical properties. Personal Care & Cosmetics only.
Lo sentimos pero la industria que ha escogido no esta disponible en el idioma seleccionado en este momentos. Usted puede seleccionar un idioma a continuación para avanzar en esta industria o cerrar este dialogo.